Clene (CLNN)

• Market cap: $48.2M
• 1 day: -1.92%
• 5 days: -22.98%
• 1 month: -31.38%
• 3 months: -59.1%
• 6 months: 17.19%
• Year to date: -29.12%
• 1 year: -13.89%
• 5 years: -96.88%
• 10 years: -97.88%
• Sector: Consumer Staples
• Industry: Packaged Foods

About: Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Employees: 76